Serina Therapeutics SER
NYSE SER
$2.00 -0.01 (-0.48%)
As of: Oct 1, 2026 · 3:14 PM EDT

Serina Therapeutics (SER) Other Operating Expenses (2018 - 2019)

Updated

Serina Therapeutics (SER) reported Other Operating Expenses of -$6.89 million for Q1 2019.

Analysis

Serina Therapeutics (SER) Other Operating Expenses (2018 - 2019) Analysis & Trends

For FY2018, Serina Therapeutics posted Other Operating Expenses of -$23.75 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Serina Therapeutics 32.93 Mn -7.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -6.89 Mn
Dec 31, 2018 -6.98 Mn
Sep 30, 2018 -5.17 Mn
API Access

Serina Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=SER&period=max&api_key=YOUR_API_KEY